© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
COMPASS Pathways plc (CMPS) stock surged +8.05%, trading at $15.17 on NASDAQ, up from the previous close of $14.04. The stock opened at $14.20, fluctuating between $14.09 and $15.86 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 13.28 | 14.45 | 13.18 | 14.04 | 3.34M |
| Sep 04, 2026 | 13.17 | 13.38 | 13.05 | 13.27 | 788.49K |
| Sep 03, 2026 | 13.03 | 13.30 | 12.73 | 13.29 | 1.81M |
| Sep 02, 2026 | 13.31 | 13.60 | 13.00 | 13.23 | 1.93M |
| Sep 01, 2026 | 13.41 | 13.49 | 13.12 | 13.24 | 1.89M |
| Aug 31, 2026 | 13.80 | 13.94 | 13.43 | 13.51 | 1.77M |
| Aug 28, 2026 | 14.60 | 14.71 | 13.69 | 13.73 | 2.64M |
| Aug 27, 2026 | 14.63 | 14.93 | 14.40 | 14.64 | 1.65M |
| Aug 26, 2026 | 14.79 | 15.01 | 14.57 | 14.61 | 1.73M |
| Aug 25, 2026 | 14.40 | 14.92 | 14.30 | 14.88 | 2.27M |
| Aug 24, 2026 | 13.41 | 14.32 | 13.08 | 14.20 | 2.77M |
| Aug 21, 2026 | 13.82 | 14.02 | 13.30 | 13.33 | 2.08M |
| Aug 20, 2026 | 14.00 | 14.20 | 13.65 | 13.82 | 1.99M |
| Aug 19, 2026 | 13.93 | 14.17 | 13.68 | 14.01 | 2.83M |
| Aug 18, 2026 | 13.55 | 14.00 | 13.22 | 13.90 | 3.27M |
| Aug 17, 2026 | 13.39 | 13.80 | 13.27 | 13.72 | 1.75M |
| Aug 14, 2026 | 13.26 | 13.48 | 13.06 | 13.45 | 1.3M |
| Aug 13, 2026 | 14.20 | 14.20 | 13.28 | 13.29 | 2.39M |
| Aug 12, 2026 | 13.75 | 14.59 | 13.65 | 14.22 | 4.08M |
| Aug 11, 2026 | 13.48 | 13.69 | 13.20 | 13.38 | 2.19M |
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.
| Employees | 156 |
| Beta | 2.53 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |